FDA inspection
Kyongbo Pharmaceutical Co., Ltd.: FDA inspection ending Nov 11, 2025
FDA inspection 1295018 · Voluntary Action Indicated (VAI) · Asan
Key facts
| Inspection ID | 1295018 |
|---|---|
| Firm | Kyongbo Pharmaceutical Co., Ltd. |
| FEI number | 3003773799 |
| Address | 174 Sirok-Ro |
| City | Asan |
| Country | Korea (the Republic of) |
| Fiscal year | 2026 |
| Inspection end date | Nov 11, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data